Dr. John Mascarenhas, MD - PV Moving Beyond Hydroxyurea MPN Advocacy and Education 33:02 6 years ago 1 392 Скачать Далее
MPN Hero Dr. John Mascarenhas: Dedicated Researcher and Clinician Voices of MPN 3:23 2 years ago 1 113 Скачать Далее
John Mascarenhas, MD, MS: Continuing to Evaluate Pacritinib for Myelofibrosis American Society of Hematology 4:59 7 years ago 657 Скачать Далее
What are MPNs? Top Specialist Talks Symptoms and Diagnosis | Dr. John Mascarenhas The Patient Story 15:35 2 years ago 913 Скачать Далее
New Drugs for MPNs - Dr. John Mascarenhas MPN Education Foundation 40:09 3 years ago 241 Скачать Далее
Latest on Current Treatments for Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia The Patient Story 16:19 2 years ago 4 257 Скачать Далее
Dr. John Mascarenhas on the COMFORT-I/II Studies for Ruxolitinib in Myelofibrosis Targeted Oncology 1:52 8 years ago 143 Скачать Далее
Dr John Mascarenhas reviews clinical trial updates at ASH 2015 PV Reporter 6:53 8 years ago 290 Скачать Далее
MPN Research and Optimism About Curative Therapies Patient Empowerment Network 2:47 2 years ago 107 Скачать Далее
Dr. Mascarenhas on Approved and Emerging Treatment Options in Myelofibrosis OncLive 2:00 3 years ago 92 Скачать Далее
My view on current and future use of JAK inhibitors for ET, PV, and MF HMP Education 29:27 6 years ago 344 Скачать Далее
Patient Considerations That Impact MPN Treatment Decisions Patient Empowerment Network 4:35 2 years ago 33 Скачать Далее
John Mascarenhas, ASH 2019: Treating Myelodysplastic Syndromes and Myeloproliferative Neoplasms Touch Medical Media Services 4:43 4 years ago 395 Скачать Далее
An Overview of ET, PV and MF Treatment Options Patient Empowerment Network 7:08 2 years ago 165 Скачать Далее
MPD-RC 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia VJHemOnc – Video Journal of Hematology & HemOnc 1:59 7 years ago 496 Скачать Далее
